{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:07:44Z","timestamp":1792724864436,"version":"4.5.0"},"reference-count":19,"publisher":"Society of Nuclear Medicine","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2024,5,22]]},"published-print":{"date-parts":[[2024,8]]},"DOI":"10.2967\/jnumed.124.267434","type":"journal-article","created":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T16:11:27Z","timestamp":1718986287000},"page":"1307-1312","source":"Crossref","is-referenced-by-count":13,"title":["RadShap: An Explanation Tool for Highlighting the Contributions of Multiple Regions of Interest to the Prediction of Radiomic Models"],"prefix":"10.2967","volume":"65","author":[{"given":"Nicolas","family":"Captier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Orlhac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narin\u00e9e","family":"Hovhannisyan-Baghdasarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Luporsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Girard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ir\u00e8ne","family":"Buvat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2024,6,21]]},"reference":[{"key":"2024080105203397000_65.8.1307.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2011.11.036"},{"key":"2024080105203397000_65.8.1307.2","first-page":"49","article-title":"Radiomic analysis in prediction of human papilloma virus status","volume":"7","author":"Yu","year":"2017","journal-title":"Clin Transl Radiat Oncol."},{"key":"2024080105203397000_65.8.1307.3","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1007\/s00259-022-05916-4","article-title":"Comparing lesion and feature selections to predict progression in newly diagnosed DLBCL patients with FDG PET\/CT radiomics features","volume":"49","author":"Eertink","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2024080105203397000_65.8.1307.4","doi-asserted-by":"crossref","first-page":"17588359221118785","DOI":"10.1177\/17588359221118785","article-title":"M1 stage subdivisions based on 18F-FDG PET-CT parameters to identify locoregional radiotherapy for metastatic nasopharyngeal carcinoma","volume":"14","author":"Qiu","year":"2022","journal-title":"Ther Adv Med Oncol."},{"key":"2024080105203397000_65.8.1307.5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/e23010018","article-title":"A review of machine learning interpretability methods","volume":"23","author":"Linardatos","year":"2020","journal-title":"Entropy (Basel)."},{"key":"2024080105203397000_65.8.1307.6","unstructured":"Rozemberczki B Watson L Bayer P . The Shapley value in machine learning. arXiv website. https:\/\/arxiv.org\/abs\/2202.05594. Published February 11, 2022. Revised May 26, 2022. Accessed May 30, 2024."},{"key":"2024080105203397000_65.8.1307.7","unstructured":"Lundberg SM Lee SI . A unified approach to interpreting model predictions. arXiv website. https:\/\/arxiv.org\/abs\/1705.07874. Published May 22, 2017. Revised November 25, 2017. Accessed May 30, 2024."},{"key":"2024080105203397000_65.8.1307.8","doi-asserted-by":"crossref","unstructured":"Shapley LS . A Value for N-Person Games. RAND Corp.; 1953.","DOI":"10.1515\/9781400881970-018"},{"key":"2024080105203397000_65.8.1307.9","unstructured":"Kennedy T . Monte Carlo Methods: A Special Topics Course. University of Arizona; 2016."},{"key":"2024080105203397000_65.8.1307.10","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1016\/j.cor.2008.04.004","article-title":"Polynomial calculation of the Shapley value based on sampling","volume":"36","author":"Castro","year":"2009","journal-title":"Comput Oper Res."},{"key":"2024080105203397000_65.8.1307.11","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-18-0125"},{"key":"2024080105203397000_65.8.1307.12","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2020191145"},{"key":"2024080105203397000_65.8.1307.13","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-0339"},{"key":"2024080105203397000_65.8.1307.14","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.annonc.2020.11.019","article-title":"Risk stratification in diffuse large B-cell lymphoma using lesion dissemination and metabolic tumor burden calculated from baseline PET\/CT","volume":"32","author":"Cottereau","year":"2021","journal-title":"Ann Oncol."},{"key":"2024080105203397000_65.8.1307.15","doi-asserted-by":"publisher","DOI":"10.1002\/sim.2149"},{"key":"2024080105203397000_65.8.1307.16","doi-asserted-by":"crossref","first-page":"1180773","DOI":"10.3389\/fmed.2023.1180773","article-title":"Explainable artificial intelligence (XAI) in radiology and nuclear medicine: a literature review","volume":"10","author":"de Vries","year":"2023","journal-title":"Front Med (Lausanne)."},{"key":"2024080105203397000_65.8.1307.17","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1002\/mp.15539","article-title":"Lung cancer diagnosis using deep attention-based multiple instance learning and radiomics","volume":"49","author":"Chen","year":"2022","journal-title":"Med Phys."},{"key":"2024080105203397000_65.8.1307.18","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1016\/j.acra.2023.03.027","article-title":"FDG PET\/CT tumor dissemination characteristic predicts the outcome of first-line systemic therapy in non-small cell lung cancer","volume":"30","author":"Tan","year":"2023","journal-title":"Acad Radiol."},{"key":"2024080105203397000_65.8.1307.19","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.3390\/cancers12082234","article-title":"Association of the metabolic score using baseline FDG-PET\/CT and dNLR with immunotherapy outcomes in advanced NSCLC patients treated with first-line pembrolizumab","volume":"12","author":"Seban","year":"2020","journal-title":"Cancers (Basel)."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.124.267434","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T12:24:28Z","timestamp":1722515068000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.124.267434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,21]]},"references-count":19,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8,1]]},"published-print":{"date-parts":[[2024,8]]}},"alternative-id":["10.2967\/jnumed.124.267434"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.124.267434","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,21]]}}}